Skip to Content
Merck
CN
  • Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

Human genetic disorders caused by mutations in genes encoding biosynthetic enzymes for sulfated glycosaminoglycans.

The Journal of biological chemistry (2013-03-05)
Shuji Mizumoto, Shiro Ikegawa, Kazuyuki Sugahara
ABSTRACT

A number of genetic disorders are caused by mutations in the genes encoding glycosyltransferases and sulfotransferases, enzymes responsible for the synthesis of sulfated glycosaminoglycan (GAG) side chains of proteoglycans, including chondroitin sulfate, dermatan sulfate, and heparan sulfate. The phenotypes of these genetic disorders reflect disturbances in crucial biological functions of GAGs in human. Recent studies have revealed that mutations in genes encoding chondroitin sulfate and dermatan sulfate biosynthetic enzymes cause various disorders of connective tissues. This minireview focuses on growing glycobiological studies of recently described genetic diseases caused by disturbances in biosynthetic enzymes for sulfated GAGs.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Chondroitin sulfate A sodium salt from bovine trachea, lyophilized powder, BioReagent, suitable for cell culture
Chondroitin sulfate sodium (marine), European Pharmacopoeia (EP) Reference Standard
Chondroitin sulfate sodium, European Pharmacopoeia (EP) Reference Standard